The structure and function of myelin oligodendrocyte glycoprotein

Journal of Neurochemistry

Volumn 72, Issue 1, 1999, Pages 1-9

  Johns, Terrance G ^a   Bernard, Claude C A ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

C1q; Galactocerebroside; Marsupial; Microtubule; Myelin; Myelin oligodendrocyte glycoprotein

Indexed keywords

GLYCOPROTEIN; MYELIN;

GLYCOPROTEIN SYNTHESIS; HUMAN; MICROTUBULE; MYELINATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

ANIMALS; DEMYELINATING DISEASES; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; SEQUENCE HOMOLOGY, AMINO ACID;

METATHERIA;

EID: 0032932360     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720001.x     Document Type: Short Survey

References (47)

1. Abo S., Bernard C. C. A., Webb M., Johns T. G., Alafaci A., Ward L. D., Simpson R. J., and Kerlero de Rosbo N. (1993) Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem. Mol. Biol. Int. 30, 945-958.
2. Amiguet P., Gardinier M. V., Zanetta J.-P., and Matthieu J.-M. (1992) Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J. Neurochem. 58, 1676-1682.
3. Ballenthin P. A. and Gardinier M. V. (1996) Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice. J. Neurosci. Res. 46, 271-281.
4. Barcellos L. F., Thomson G., Carrington M., Schafer J., Begovich A. B., Lin P., Xu X., Min B., Marti D., and Klitz W. (1997) Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. JAMA 278, 1256-1261.
5. Benjamins J. A. and Nedelkoska L. (1994) Maintenance of membrane sheets by cultured oligodendrocytes requires continuous microtubule turnover and Golgi transport. Neurochem. Res. 19, 631-639.
6. Bernard C. C. A., Johns T. G., Slavin A. J., Ichikawa M., Ewing C., Liu J., and Bettadapura J. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75, 77-88.
7. Berndt J. A., Kim J. G., and Hudson L. D. (1992) Identification of cis-regulatory elements in the myelin proteolipid protein (PLP) gene. J. Biol. Chem. 267, 14730-14737.
8. Bettadapura J., Menon K. K., Moritz S., Liu J., and Bernard C. C. A. (1998) Expression, purification and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J. Neurochem. 70, 1593-1599.
9. Birling M. C., Roussel G., Nussbaum F., and Nussbaum J. L. (1993) Biochemical and immunohistochemical studies with specific polyclonal antibodies directed against bovine myelin/oligodendrocyte glycoprotein. Neurochem. Res. 18, 937-945.
10. Brunner C., Lassmann H., Waehneldt T. V., Matthieu J.-M., and Linington C. (1989) Differential ultrastructural localisation of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52, 296-304.
11. 0: assessment of the structures bearing the epitope for HNK-1 and human monoclonal immunoglobulin M found in demyelinating neuropathy. J. Neurochem. 58, 854-861.
12. Burger D., Steck A. J. C., Bernard C. C. A., and Kerlero De Rosbo N. (1993) Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. J. Neurochem. 61, 1822-1827.
13. Casey P. J. (1995) Protein lipidation in cell signaling. Science 268, 221-225.
14. Daubas P., Pham-Dinh D., and Dautigny A. (1994) Structure and polymorphism of the mouse myelin/oligodendrocyte glycoprotein gene. Genomics 23, 36-41.
15. Dubois-Dalcq M. and Armstrong R. (1990) The cellular and molecular events of central nervous system remyelinauon. Bioessays 12, 569-576.
16. Dunlop S. A., Coleman L. A., Harman A. M., and Beazley L. D. (1988) Development of the marsupial primary visual pathway, in The Developing Marsupial (Tindale-Biscoe C. H. and Janssens P. A., eds), pp. 117-131. Springer-Verlag, Heidelberg.
17. Dyer C. A. (1993) Novel oligodendrocyte transmembrane signaling systems: investigations utilizing antibodies as ligands. Mol. Neurobiol. 7, 1-22.
18. Dyer C. A. and Matthieu J.-M. (1994) Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J. Neurochem. 62, 777-787.
19. Gardinier M. V. and Ballenthin P. A. (1997) A subpopulation of neutrophils express myelin/oligodendrocyte glycoprotein on the cell surface (Abstr.), in Frontiers of Myelin Biology and Demyelinating Disease, ISN Satellite and UConn-Kroc Symposium, Mystic, Connecticut, p. 87. University of Connecticut, Storrs.
20. Gardinier M. V., Amiguet P., Linington C., and Matthieu J.-M. (1992) Myelin/oligodendrocyte glycoprotein is a unique member of immunoglobulin superfamily. J. Neurosci. Res. 33, 177-187.
21. Hilton A. A., Slavin A. J., Hilton D. J., and Bernard C. C. A. (1995) Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J. Neurochem. 65, 309-318.
22. Hudson L. D., Ko N., and Kim J. G. (1995) Control of myelin gene expression, in Glial Cell Development: Basic Principle of Clinical Relevance (Richardson W. D. and Jessen K. R., eds). pp. 101-121. Bios Scientific Publishers, London.
23. Johns T. G. and Bernard C. C. A. (1997) Binding of component C1q to myelin oligodendrocyte glycoprotein: a novel mechanism for regulating CNS inflammation. Mol. Immunol. 34, 33-38.
24. Johns T. G., Kerlero de Rosbo N., Menon K. K., Abo S., Gonzales M. F., and Bernard C. C. A. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154, 5536-5541.
25. Kerlero de Rosbo N., Clark R. M., Fernando R., Stuart S. J., Wang J., and Bernard C. C. A. (1993) New myelin basic protein isoforms in marsupial cat. (Abstr.) J. Neurochem. 61 (Suppl.), S193.
26. Korb L. C. and Ahearn J. M. (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528.
27. Kroepfl J. F., Viise L. R., Charron A. J., Linington C., and Gardinier M. V. (1996) Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J. Neurochem. 67, 2219-2222.
28. Lebar R., Boutry J. M., Vincent C., Roubineaux R., and Voisin G. A. (1976) Studies on autoimmune encephalomyelitis in guinea pig. II. An in vitro investigation on the nature, properties and specificity of serum demyelinating factor. J. Immunol. 116, 1439-1446.
29. Li C., Tropak M. B., Gerlai R., Clapoff S., Abramow-Newerly W., Trapp B., Peterson A., and Roder J. (1994) Myelination in the absence of myelin-associated glycoprotein. Nature 369, 747-750.
30. Linington C., Webb M., and Woodhams P. L. (1984) A novel myelin associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6, 387-396.
31. Linsley P. S., Peach R., Gladstone P., and Bajorath J. (1994) Extending the B7 (CD80) gene family. Protein Sci. 3, 1341-1343.
32. Mather I. H. and Lucinda J. J. W. (1993) A review of the molecular and cellular biology of butyrophilin, the major protein of bovine milk fat globule membrane. J. Dairy Sci. 76, 3832-3850.
33. Menon K. K., Piddlesden S. J., and Bernard C. C. A. (1997) Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin. J. Neurochem. 69, 214-222.
34. Nave K. A. and Lemke G. (1991) Induction of the myelin proteolipid protein (PLP) gene in C6 glioblastoma cells: functional analysis of the PLP promoter. J. Neurosci. 11, 3060-3069.
35. Pham-Dinh D., Mattei M.-G., Nussbaum J.-L., Roussel G., Pontarotti P., Roeckel N., Mather I. H., Artzt K., Lindahl K. F., and Dautigny A. (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc. Natl. Acad. Sci. USA 90, 7990-7994.
36. Pham-Dinh D., Jones E. P., Pitiot G., Gaspera B. D., Daubas P., Mallet J., Le Paslier D., Lindahl K. F., and Dautigny A. (1995) Physical mapping of the human and mouse MOG gene at the distal end of the MHC class 1b region. Immunogenetics 42, 386-391.
37. 2+-calmodulin regulated effectors of microtubule stability in bovine brain. Biochemistry 31, 8849-8855.
38. Quarles R. H. (1997) Glycoproteins of myelin sheaths. J. Mol. Neurosci. 8, 1-11.
39. Rodriguez D., Della Gaspera B., Zalc B., Hauw J. J., Fontaine B., Edan G., Clanet M., Dautigny A., and Pham-Dinh D. (1997) Identification of a Val 145 Ile substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. Mult. Scler. 3, 377-381.
40. Roth M. P., Dolbois L., Borot N., Pontarotti P., Clanet M., and Coppin H. (1995) Myelin oligodendrocyte glycoprotein (MOG) gene polymorphisms and multiple sclerosis: no evidence of disease association with MOG. J. Neuroimmunol. 61, 117-122.
41. Scolding N. J., Frith S., Linington C., Morgan B. P., Campbell A. K., and Compston D. A. S. (1989a) Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J. Neuroimmunol. 22, 169-176.
42. Scolding N. J., Morgan B. P., Houston A., Campbell A. K., Linington C., and Compston D. A. S. (1989b) Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies. J. Neurol. Sci. 89, 289-300.
43. Slavin A., Johns T., Orian J., and Bernard C. C. A. (1997) Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev. Neurosci. 19, 69-78.
44. Solly S. K., Thomas J. L., Monge M., Demerens C., Lubetzki C., Gardinier M. V., Matthieu J.-M., and Zalc B. (1996) Myelin/ oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 18, 39-48.
45. Solly S. K., Daubas P., Monge M., Dautigny A., and Zalc B. (1997) Functional analysis of the mouse myelin/oligodendrocyte glycoprotein gene promoter in the oligodendroglial CG4 cell line. J. Neurochem. 68, 1705-1711.
46. Vanguri P. and Shin M. L. (1986) Activation of complement by myelin: identification of C1-binding proteins of human myelin from central nervous tissue. J. Neurochem. 46, 1535-1541.
47. Wren D. R. and Noble M. (1989) Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc. Natl. Acad. Sci. USA 86, 9025-9029.